weight watchers and glp 1 Goes All-In on GLP-1s With App Overhaul Starting a GLP-1 is a

Patients not on treatment or on other antihyperglycemic agents entered a run-in treatment period of up to 12 weeks duration with metformin monotherapy (dose of greater than or equal to 1500 mg per day) which included washout of medications other than metformin, if applicable

This improves how the body manages glucose and supports weight loss

Studies show rebound weight gain after stopping medication is a serious issue 1 , and its not a method that should be relied on forever

The administration also announced that it would expedite approvals of these much-anticipated, less-expensive GLP-1 medications

Studies are also finding that using a GLP-1 agonist is linked to lowering the risk of heart attack, heart disease, stroke, and kidney disease

Patient selection should consider contraindications, including personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (boxed warning), and hypersensitivity to semaglutide or any product components